Hugel, Inc. (KOSDAQ: A145020)
Health Care · Biotechnology · KR
₩182,800.00
+1.50% today · -31.8% 1Y
Hugel, Inc. (KOSDAQ: A145020) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.47B.
Over the last twelve months the share price has lost 31.8%, trading between 175.50K and 308.50K.
Tweenvest scores Hugel, Inc. across four factors: quality 95/100, value 87/100. Its strongest factor is quality.
A145020 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.47B
- Revenue (TTM)
- $309.68M
- P/E
- 12.69
- EPS
- 14,402.61
- Dividend yield
- —
- Beta (5Y)
- 0.56
- 52-week high
- ₩308,500.00
- 52-week low
- ₩175,500.00
- Avg volume (3M)
- —
- Shares outstanding
- 10.80M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Immunocore Holdings plcNasdaqGS: IMCR | $1.51B | $29.05 | -1.16% |
| Wedge Industrial Co.,Ltd.SZSE: 000534 | $1.50B | CN¥20.79 | -3.88% |
| InventisBio Co., LimitedSHSE: 688382 | $1.49B | CN¥17.26 | -9.49% |
| Staidson (Beijing) BioPharmaceuticals Co., Ltd.SZSE: 300204 | $1.47B | CN¥20.66 | +1.08% |
| Taysha Gene Therapies, Inc.NasdaqGS: TSHA | $1.46B | $4.17 | -7.24% |
| D&D Pharmatech Inc.KOSDAQ: A347850 | $1.46B | ₩42,850.00 | -0.35% |
| Bonesupport Holding AB (publ)OM: BONEX | $1.45B | Skr242.60 | +8.98% |
| Nektar TherapeuticsNasdaqCM: NKTR | $1.41B | $39.72 | -3.52% |
Figures last refreshed Oct 11, 2026.